The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Associations of early adverse events with clinical outcomes in patients with NSCLC treated with EGFR tyrosine kinase inhibitors.
 
Fang-Ju Lin
Research Funding - Boehringer Ingelheim; Novartis
 
Wen-Yen Lin
No Relationships to Disclose
 
Chi-Chuan Wang
No Relationships to Disclose
 
Jin-Yuan Shih
Honoraria - ACT Genomics; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; CStone Pharmaceuticals; GlaxoSmithKline; Janssen; Lilly; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical; Orient EuroPharma; Pfizer; Roche; Takeda; TTY Biopharm
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche; Takeda
Research Funding - Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Pfizer; Roche